- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Stent-graft in New Zealand
Total 205 results
-
NYU Langone HealthWithdrawn
-
NYU Langone HealthCompleted
-
Boston Scientific CorporationActive, not recruiting
-
Mayo ClinicEnrolling by invitation
-
Midwest Cardiovascular Research FoundationCompletedFemoropopliteal In-stent RestenosisUnited States
-
Columbia UniversityIncyte CorporationTerminatedGraft Vs Host Disease | Steroid Refractory GVHDUnited States
-
University of RochesterWithdrawnActive Chronic Graft Versus Host DiseaseUnited States
-
NYU Langone HealthRecruiting
-
NYU Langone HealthActive, not recruitingGraft-versus-host DiseaseUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedGraft Versus Host DiseaseUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedGraft Versus Host DiseaseUnited States
-
Yale UniversityTerminatedGraft Versus Host DiseaseUnited States
-
University of RochesterTerminatedChronic Graft Versus Host DiseaseUnited States
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States, Spain, Belgium, France, Italy, Korea, Republic of, Finland, United Kingdom, Germany, Israel, Switzerland, Austria, Australia, Czechia, Greece, New Zealand, Poland, Portugal, Taiwan
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedGraft Versus Host DiseaseUnited States, Canada, Australia, Switzerland, Puerto Rico, New Zealand
-
EquilliumBiocon LimitedRecruitingGraft Versus Host Disease | GVHD | aGVHD | Acute-graft-versus-host Disease | Acute GVHDUnited States, Korea, Republic of, Germany, Israel, Spain, Belgium, Italy, Australia, France, Canada, Portugal, New Zealand
-
Mesoblast, Inc.No longer availableGraft-Versus-Host DiseaseUnited States
-
Northwell HealthWithdrawnAcute GVH DiseaseUnited States
-
Alexion PharmaceuticalsTerminatedAcute Graft-Versus-Host Disease | GIGVHDUnited States, France
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedGraft Versus Host Disease | Hematopoietic Cell Transplantation RecipientUnited States
-
NYU Langone HealthRecruitingGraft Vs Host DiseaseUnited States
-
Columbia UniversityCompletedImplant or Graft; RejectionUnited States
-
SoligenixTerminatedChronic Gastrointestinal Graft vs Host DiseaseUnited States
-
Abbott Medical DevicesCompletedMyocardial Ischemia | Coronary Artery Disease | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Stents | Total Coronary Occlusion | Coronary Artery RestenosisUnited States
-
NYU Langone HealthCompleted
-
Regimmune CorporationCompletedGraft Vs Host Disease | Graft-versus-host-disease | Acute-graft-versus-host Disease | Prevention of aGVHDUnited States
-
Roswell Park Cancer InstituteCompletedGraft Versus Host DiseaseUnited States
-
Genentech, Inc.TerminatedAcute Graft-versus-host DiseaseUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedGraft Versus Host DiseaseUnited States
-
Hackensack Meridian HealthTerminatedGraft Versus Host DiseaseUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedGraft Versus Host DiseaseUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Graft Versus Host DiseaseUnited States
-
Incyte CorporationApproved for marketingGraft-versus-host Disease (GVHD)United States
-
Genentech, Inc.Completed
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States
-
Cynata Therapeutics LimitedCompletedGraft vs Host DiseaseAustralia, United Kingdom
-
MallinckrodtParexelCompletedChronic Graft Versus Host DiseaseUnited States, France, Germany, United Kingdom, Spain, Italy, Austria, Hungary
-
Massachusetts General HospitalDana-Farber Cancer Institute; Seagen Inc.Completed
-
NovartisCompletedKidney Transplantation | Graft RejectionUnited States
-
John LevineCompletedGVHD | Low Risk Acute Graft-versus-host Disease | Graft-versus-host-diseaseUnited States
-
EVIVE BiotechnologyMemorial Sloan Kettering Cancer CenterCompletedAcute Graft vs Host DiseaseUnited States
-
NYU Langone HealthWithdrawn
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedGraft Rejection | Kidney FailureUnited States, Spain, Canada, Switzerland, Austria, Australia, New Zealand
-
The University of QueenslandBaxter Healthcare Corporation; Health Research Council, New Zealand; Australian...CompletedEnd Stage Kidney Disease | Kidney Transplant; Complications | Delayed Graft FunctionAustralia, New Zealand
-
Memorial Sloan Kettering Cancer CenterCompletedCD34 Selected Peripheral Blood Stem Cell GraftUnited States
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States
-
PlexisionMedical University of South CarolinaUnknownAntibody-Mediated Graft RejectionUnited States
-
John LevineBiogenCompletedAcute Graft Versus Host DiseaseUnited States
-
Jazz PharmaceuticalsCompletedAcute-graft-versus-host Disease | Graft-versus-host DiseaseUnited States, Belgium, United Kingdom, Greece, Germany, Spain, France, Italy, Austria, Canada, Bulgaria, Croatia, Poland, Portugal